Kymera Therapeutics, Inc. (KYMR) NASDAQ

38.79

+0.0575(+0.15%)

Updated at February 05 11:00AM

Currency In USD

Valuation

Market Cap1.49B
Enterprise Value1.46B
P/E Ratio-17.81
PEG Ratio-5.39
Price/Sales Ratio28.98
Price/Book Ratio3.34
Enterprise/Revenue28.73
Enterprise/EBITDA-15.63

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin-1.91
Operating Margin-2.23

Management Effectiveness

Return On Assets-0.16
Return On Equity-0.25

Income Statement

Revenue78.59M
Revenue/Share1.15
Gross Profit-110.49M
EBITDA-143.2M
Net Income-146.96M
Diluted EPS-2.52

Balance Sheet

Total Cash549.97M
Total Cash/Share7.22
Total Debt88.23M
Total Debt/Equity0.1
Current Ratio8.55
Book Value Per Share11.73

Price History

52-Week Change15.66
52-Week High53.27
52-Week Low29.24
Moving Average 50 Days42.38
Moving Average 200 Days41.6

Statistics

Average Volume486,101
Shares Outstanding64.77M
% Held by Institutions90.59

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A